Magnesium status of the environment and population morbidity rate of arterial hypertension

Cover Page

Cite item

Full Text

Abstract

Introduction. Study of the interrelation between magnesium content in biosphere objects (soil, natural water, plants) with arterial hypertension (AH) incidence among the population living in the territory of the plain Dagestan (Babayurtovsky, Kizlyar, Tarumovsky and Nogai districts of the Republic).

Material and Methods. To assess the development of hypertension, the data were obtained from the medical information center of the Ministry of Health of Dagestan. Samples of soil, water, plants with the determination of the magnesium content in them were processed by the photometric method in the biogeochemical laboratory of the Prikaspiyskiy Institute of Biology Resources of Daghestan Scientific Centre of the Russian Academy of Sciences. For analyzes, the material was selected in the summer months. The correlation coefficients are calculated by Pearson.

Results. When comparing the incidence rates of AH for 2005-2007 with the magnesium content in soils, natural waters, plants, a negative average correlation of magnesium concentration in the study sites with the incidence of AH population was established in the study area. A number of patients in the studied years was also noted to be changing, but the dependence of the incidence of AH of the population on the magnesium content in the biosphere objects is preserved.

Conclusions. One of the factors of occurrence and course of hypertension is the magnesium status of the population, which depends on the geochemical features of the territory. As a result of the study, it was found that the higher the magnesium content in biosphere objects, the lower the incidence of AH population. In order to reduce the AH values among the population, it is necessary to correct the lack of magnesium in the human body with magnesium additives, which contribute to the regulation of blood pressure and reduce the risk of cardiovascular diseases. In connection with the possible subclinical magnesium deficiency, an important factor in informing about the possible morbidity of hypertension is information on the magnesium content in environmental objects.

About the authors

M. A. Yahyaev

Research Institute of Environmental Medicine Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation; Precaspian Institute of Biological Resources of Dagestan Scientific Center RAS

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

Shamil K. Salikhov

Precaspian Institute of Biological Resources of Dagestan Scientific Center RAS

Email: salichov72@mail.ru
ORCID iD: 0000-0001-5531-3045

Researcher of the Laboratory of Soil and Plant Resources of the Prikaspiyskiy Institute of Biology Resources of Daghestan Scientific Centre of the Russian Academy of Sciences, Makhachkala, 367000, Russian Federation.

e-mail: salichov72@mail.ru

Russian Federation

S. O. Abdulkadyrova

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

A. Sh. Aselderova

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

Z. Z. Surkhayeva

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

P. D. Kazanbiyeva

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

E. I. Ibragimova

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

D. Z. Alieva

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

M. A. Adilova

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

B. A. Abusueva

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

Z. S. Abusueva

Federal State Budgetary Educational Institution of Higher Education «Dagestan State Medical University» of the Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru
Russian Federation

References

  1. Maksikova T.M., Kalyagin A.N. Problems of identification and management of patients with cardiovascular risk factors in health centers for adults (part 1). Izvestiya vysshih uchebnyh zavedenij. Povolzhskij region. Medicinskie nauki [Proceedings of higher educational institutions. The Volga region. Medical sciences]. 2017; 2 (42): 135-153. https://doi.org/10.21685/2072-3032-2017-2-14 (In Russian)
  2. Israili Z.H., Hernandez-Hernandez R., Valasco M. The future of antihypertensive treatment. American Journal of Therapeutics. 2007; 14 (2): 121-134. https://doi.org/10.1097/01.pap.0000249915.12185.58
  3. Oshchepkova E.V. Mortality from cardiovascular diseases in the Russian Federation in the 2001- 2006 biennium. and ways to reduce it. Kardiologiya.[Cardiology]. 2009; 2: 67–73. (In Russian)
  4. Shalnova S.A., Deev A.D. Mortality Trends in Russia at the beginning of the XXI century (according to official statistics). Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular therapy and prevention]. 2011; 10 (6): 5–10. (In Russian)
  5. Global summary on arterial hypertension. A silent killer, a global public health crisis. World Health Organization. Geneva. 2013. (In Russian)
  6. Oganov R.G., Maslennikova G.Ya. The epidemic of cardiovascular diseases can be stopped by increased prevention. Profilakticheskaya medicin [Prophylactic medicine]. 2009; 12 (6): 3-7. (In Russian)
  7. Prevalence of non-infectious disease risk factors in the Russian population in 2012-2013. Results of the ESSE-RF study. Kardiovaskulyarnaya terapiya i profilaktika [Cardiovascular therapy and prevention]. 2014; 6: 4-11. (In Russian)
  8. Balanova Yu.A., Kontsevaya A.V., Shalnova S.A. The prevalence of behavioral risk factors for cardiovascular diseases in the Russian population: the results of the epidemiological study of ESSE-RF. Profilakticheskaya medicin [Prophylactic medicine]. 2014; 17 (5): 42-52. (In Russian)
  9. Fuchs F.D. Essentials of Hypertension: The 120/80 paradigm. New York: Springer. 2018. 160 p. https://doi.org/10.1007/978-3-319-63272-8
  10. Laurant P., Touyz R.M. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J. Hypertens. 2000; 18(9): 1177–1191.
  11. Wexler R, Aukerman G. Nonpharmacologic strategies for managing hypertension. J. American Family Physician. 2006; 1(7): 3–11.
  12. Sontia B., Touyz R.M. Role of magnesium in hypertension. J. Arch Biochem Biophys. 2007; 1(1): 33–39.
  13. Houston M. Magnesium and Hypertension. In: Watson R., Preedy V., Zibadi S. (eds) Magnesium in Human Health and Disease. Nutrition and Health. Humana Press, Totowa, NJ. 2013; 183-189. https://doi.org/10.1007/978-1-62703-044-1_12
  14. Indicators of health status of the population of the Republic of Dagestan. 2006-2008. Makhachkala: RMIAC MH RD: LLC Matrica. (In Russian)
  15. Grindel NM Photometric methods in soil analysis. A Practical Guide. M.: Moscow State University; 1982. 59–71. (In Russian)
  16. Petrukhin I.V. Quantitative determination of magnesium in water, feed, liquids and animal tissues through the FEC-M apparatus. Proceedings of Smolensk Research Institute of Veterinary Station. 1960; 1: 188–200. (In Russian)
  17. Drozdova E.V., Buraya V.V., Surovets T.Z., Firago A.V., Girina V.V. Assessment of drinking water consumed by the population of the Republic of Belarus, according to macro- and microelement composition. Medicina truda i ekologiya cheloveka. [Occupational medicine and human ecology]. 2017; 1: 44-49. (In Russian)
  18. Calcium and Magnesium in Drinking-water: Public health significance. WHO. Geneva, 2009.
  19. Chepurnaya O.P. Distribution characteristics of hypertension in biogeochemical regions of Chuvashia. Mikroelementy v medicine [Trace Elements in Medicine]. 2002; 3 (3): 20–23. (In Russian)
  20. Tubek S. Role of trace elements in primary arterial hypertension: is mineral water style or prophylaxis? J. Biol Trace Elem Res. 2006; 1(3): 1–6.
  21. Makarova T.P., Habibrahmanova Z.R., Sadykov D. Indicators exchange of micro- and macro-elements in patients with essential hypertension patients living in areas with different environmental conditions. Kazanskij medicinskij zhurnal [Kazan Medical Journal]. 2013; 94 (6): 798–803. (In Russian)
  22. Borisova I.Yu., Makarov V.L., Churina S.K. Arterial pressure and indices of mineral metabolism in the organized population of adolescents of early peripubertal and initial pubertal periods (ecology of natural deficiencies). Arterial’naya gipertenziya [Arterial hypertension]. 2014; 20 (5): 391-400. (In Russian)
  23. Lina S. Hatzistavri, Pantelis A. Sarafidis, Panagiotis I. Georgianos, Ioannis M. Tziolas, Costas P. Aroditis, Pantelis E. Zebekakis, Maria I. Pikilidou, Anastasios N. Lasaridis Oral Magnesium Supplementation Reduces Ambulatory Blood Pressure in Patients With Mild Hypertension. American Journal of Hypertension. 2009; 22 (10): 1070-1075. https://doi.org/10.1038/ajh.2009.126
  24. Kisters K. Oral magnesium supplementation improves borderline hypertension. Magnes. Res. 2011; 24 (1): 17. https://doi.org/10.1684/mrh.2011.0273
  25. Gröber U., Schmidt J., Kisters K. Magnesium in prevention and therapy. Pitatel’nye veshchestva [Nutrients]. 2015; 7: 8199-226. https://doi.org/10.3390/nu7095388
  26. Vasilevsky I.V. A new form of adjuvant therapy in clinical medicine. Medicinskie novosti [Medical News]. 2017; 6 (273): 47-50. (In Russian)
  27. Kass L., Weekes J., Carpenter L. Effect of magnesium supplementation on blood pressure: A meta-analysis. European Journal of Clinical Nutrition. 2012; 66: 411-418. https://doi.org/10.1038/ejcn.2012.4
  28. Rosanoff. A., Plesset. M.R. Oral magnesium supplements decrease in high blood pressure (SBP> 155 mm Hg) in hypertensive subjects on anti-hypertensive medications: A targeted meta-analysis. Magnes. Res. 2013; 26: 93-99. https://doi.org/10.1684/mrh.2013.0343
  29. Huitrón-Bravo G.G., Denova-Gutiérrez E., de Jesús G-G.J., Talavera J.O., Herreros B., Salmerón J. Dietary magnesium intake and risk of hypertension in a Mexican adult population: a cohort study. BMC Nutrition. 2015; 1: 6. https://doi.org/10.1186/2055-0928-1-6
  30. DiNicolantonio J.J., O’Keefe J.H., Wilson W. Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart. 2018; 5: e000668. https://doi.org/10.1136/openhrt-2017-000668

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Yahyaev M.A., Salikhov S.K., Abdulkadyrova S.O., Aselderova A.S., Surkhayeva Z.Z., Kazanbiyeva P.D., Ibragimova E.I., Alieva D.Z., Adilova M.A., Abusueva B.A., Abusueva Z.S.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 37884 от 02.10.2009.